404
Neurotechnology Market Report
Global Neurotechnology Market, Dynamics, Market Analysis
The report on the Global Neurotechnology Market is segmented By Product Type (Imaging Modalities [Magnetic Resonance Imaging(MRI), Computed Tomography (CT), Positron Emission Tomography (PET)], Neurostimulation [Transcranial Magnetic Stimulation (TMS), Transcranial Direct Current Stimulation(tDCS)], Cranial Surface Measurement [Electroencephalography(EEG), Magnetoencephalography(MEG)], Neurological Implants), By End-Use (Hospitals, Clinics, Diagnostic Centers, Ambulatory Surgical Centers), and Region. It also focuses on the COVID-19 Impact Analysis and Forecast to 2026.
This market research report provides in-depth information on trends, dynamics, revenue opportunities, competitive landscape, and recent developments in the global neurotechnology market. The historic years considered for the study are 2016-2019, the base year is 2020, the estimated year is 2021, and the forecast period is 2022-2026.
The report is delivered digitally through our online portal. Buyers receive login credentials from our team to access the report and may update their credentials at any time after the initial login.
Delivery timelines depend on the status of the report:
For the most accurate delivery timeline, please contact us to confirm the current status of the report.
Yes. You may request a complimentary preview of the report through a video conference with our team.
Yes. The scope of the report can be fully customized to align with your specific research objectives and information requirements.
Please contact us at [email protected], and our team will be happy to discuss your requirements and propose a tailored solution.
Yes. Selected sections of the report can be purchased separately based on your requirements. Please contact us at [email protected] to discuss your needs.
Yes, AI can help gather publicly available information, but its outputs are only as reliable as the data it accesses. Stratview Research reports are built using validated data, extensive primary interviews with industry stakeholders, and the expertise of our experienced research team.
Additionally, many critical insights, including market dynamics, competitive intelligence, and industry-specific trends, are not publicly available and therefore cannot be captured through AI alone.
The neurotechnology market is expected to witness an impressive CAGR of 15.3% CAGR in the foreseeable future.
The neurotechnology market size is expected to reach USD 21.9 billion in the coming years.
General Electric Company (The U.S), Siemens Healthineers (Germany), Koninklijke Philips N.V. (Netherlands), Toshiba Medical Systems Corporation (Japan), Shimadzu Corporation (Japan), Hitachi Medical Corporation (Japan), Elekta AB (Sweden), Tristan Technologies, Inc. (The U.S), Natus Medical Incorporated (The U.S) and Magstim (UK) are among the key players in the neurotechnology market.
North America held the largest share in the neurotechnology market in 2020.
The imaging modalities segment accounted for the largest share of neurotechnology market in 2020.
The advent of new technological advancement products, growing incidences and prevalence of neurological disorders coupled with rising funding from both private and public organizations are the factors driving the growth of neurotechnology market.
Neurotechnology companies, Neurotechnology vendors, Imaging companies, R&D organizations, Hospitals are the target audience in the neurotechnology market.